aromasil has been researched along with apatinib in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jia, Y; Liu, Y; Lu, Y; Nong, L; Qin, F; Tan, A; Tang, J; Wang, H; Zhong, W | 1 |
1 trial(s) available for aromasil and apatinib
| Article | Year |
|---|---|
Phase II study of apatinib plus exemestane in estrogen receptor-positive, human epidermal growth factor receptor 2-negative metastatic breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Humans; Receptors, Estrogen; Vascular Endothelial Growth Factor A | 2023 |